Literature DB >> 19350381

Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells.

V Rhein1, G Baysang, S Rao, F Meier, A Bonert, F Müller-Spahn, A Eckert.   

Abstract

Evidence suggests that amyloid-beta (Abeta) protein is a key factor in the pathogenesis of Alzheimer's disease (AD) and it has been recently proposed that mitochondria are involved in the biochemical pathway by which Abeta can lead to neuronal dysfunction. Here we investigated the specific effects of Abeta on mitochondrial function under physiological conditions. Mitochondrial respiratory functions and energy metabolism were analyzed in control and in human wild-type amyloid precursor protein (APP) stably transfected human neuroblastoma cells (SH-SY5Y). Mitochondrial respiratory capacity of mitochondrial electron transport chain (ETC) in vital cells was measured with a high-resolution respirometry system (Oxygraph-2k). In addition, we determined the individual activities of mitochondrial complexes I-IV that compose ETC and ATP cellular levels. While the activities of complexes I and II did not change between cell types, complex IV activity was significantly reduced in APP cells. In contrast, activity of complex III was significantly enhanced in APP cells, as compensatory response in order to balance the defect of complex IV. However, this compensatory mechanism could not prevent the strong impairment of total respiration in vital APP cells. As a result, the respiratory control ratio (state3/state4) together with ATP production decreased in the APP cells in comparison with the control cells. Chronic exposure to soluble Abeta protein may result in an impairment of energy homeostasis due to a decreased respiratory capacity of mitochondrial electron transport chain which, in turn, may accelerate neurons demise.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350381     DOI: 10.1007/s10571-009-9398-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  31 in total

1.  Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities.

Authors:  C S Casley; L Canevari; J M Land; J B Clark; M A Sharpe
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

Review 2.  Mitochondria in Alzheimer's disease.

Authors:  Russell H Swerdlow; Stephen J Kish
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

3.  Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

Authors:  Casper Caspersen; Ning Wang; Jun Yao; Alexander Sosunov; Xi Chen; Joyce W Lustbader; Hong Wei Xu; David Stern; Guy McKhann; Shi Du Yan
Journal:  FASEB J       Date:  2005-10-06       Impact factor: 5.191

Review 4.  Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Dong Liu
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

5.  Biophysical and structural characterization of proton-translocating NADH-dehydrogenase (complex I) from the strictly aerobic yeast Yarrowia lipolytica.

Authors:  R Djafarzadeh; S Kerscher; K Zwicker; M Radermacher; M Lindahl; H Schägger; U Brandt
Journal:  Biochim Biophys Acta       Date:  2000-07-20

6.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

7.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

8.  Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice.

Authors:  Anne Eckert; Susanne Hauptmann; Isabel Scherping; Jessica Meinhardt; Virginie Rhein; Stefan Dröse; Ulrich Brandt; Marcus Fändrich; Walter E Müller; Jürgen Götz
Journal:  J Mol Med (Berl)       Date:  2008-08-16       Impact factor: 4.599

9.  Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.

Authors:  Sandra M Cardoso; Isabel Santana; Russell H Swerdlow; Catarina R Oliveira
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

10.  Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease.

Authors:  P Fernández-Vizarra; A P Fernández; S Castro-Blanco; J Serrano; M L Bentura; R Martínez-Murillo; A Martínez; J Rodrigo
Journal:  Histol Histopathol       Date:  2004-07       Impact factor: 2.303

View more
  68 in total

1.  Vildagliptine protects SH-SY5Y human neuron-like cells from Aβ 1-42 induced toxicity, in vitro.

Authors:  Alim Hüseyin Dokumacı; Mukerrem Betul Yerer Aycan
Journal:  Cytotechnology       Date:  2019-04-09       Impact factor: 2.058

2.  Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.

Authors:  R Derungs; G G Camici; R D Spescha; T Welt; C Tackenberg; C Späni; F Wirth; A Grimm; A Eckert; R M Nitsch; L Kulic
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

Review 3.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

Review 5.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

6.  Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function.

Authors:  Diego Mastroeni; Omar M Khdour; Pablo M Arce; Sidney M Hecht; Paul D Coleman
Journal:  ACS Chem Neurosci       Date:  2015-02-24       Impact factor: 4.418

7.  miR-146a Dysregulates Energy Metabolism During Neuroinflammation.

Authors:  Sujung Jun Kim; Ashley E Russell; Wei Wang; Darren E Gemoets; Saumyendra N Sarkar; James W Simpkins; Candice M Brown
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-24       Impact factor: 4.147

Review 8.  Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?

Authors:  Nadia Cummins; Jürgen Götz
Journal:  Cell Mol Life Sci       Date:  2017-10-30       Impact factor: 9.261

9.  Monitoring of neuronal loss in the hippocampus of Aβ-injected rat: autophagy, mitophagy, and mitochondrial biogenesis stand against apoptosis.

Authors:  Fatemeh Shaerzadeh; Fereshteh Motamedi; Dariush Minai-Tehrani; Fariba Khodagholi
Journal:  Neuromolecular Med       Date:  2013-11-08       Impact factor: 3.843

10.  Aging, Proteotoxicity, Mitochondria, Glycation, NAD and Carnosine: Possible Inter-Relationships and Resolution of the Oxygen Paradox.

Authors:  Alan R Hipkiss
Journal:  Front Aging Neurosci       Date:  2010-03-18       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.